Appearance and Shape (20°C) | Solid |
---|---|
CAS RN | 155648-60-5 |
MDL number | MFCD00890772 |
Molecular weight | 340.17 |
Molecular Formula | C9H12N2O7P2·H2O |
Product code | ICTM2360 |
PubChem Substance ID | 253660080 |
Purity/Analytical Methods | >98.0%(HPLC) |
Reaxys-RN | 19668048 |
Appearance | White to Light yellow to Light red powder to crystal |
---|
Pictograms | |
---|---|
Hazard statement | H301 : Toxic if swallowed H361 : Suspected of damaging fertility or the unborn child. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant P270 : Do not eat, drink or smoke when using this product P202 : Do not handle until all safety precautions have been read and understood P201 : Obtain special instructions before use P264 : Wash skin thoroughly after handling P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection P308 + P313 : IF exposed or concerned: Get medical advice/ attention P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth P405 : Store locked up. |
Signal word | Danger |
RTECS# | SZ8562470 |
---|
Category | 6.1 |
---|---|
Packaging category | III |
UN number | UN2811 |
Chemicals by Class Compounds by Element Classes Phosphorous Compounds [Chemical Structural Class] Phosphonates [Chemical Structural Class] Phosphonic Acids & Phosphonic Acid Salts [Chemical Structural Class]
Life Science Biochemicals and Reagents Pharmaceutical Ingredients (for Research and Experimental Use) Anti-osteoporosis Ingredients (for Research and Experimental Use) Bone Resorption Inhibitors Cell Biology Cancer Research Cancer Metabolism Inhibitors of Mevalonate Pathway Pharmaceutical Development and Drug Discovery Research Pharmaceutical Ingredients (for Research and Experimental Use) Anti-osteoporosis Ingredients (for Research and Experimental Use) Bone Resorption Inhibitors